Future Care for Medical Industries (FCMI) results, Q2 2025
Net profit, assets, equity and cash flow for Q2 2025, against the same period a year earlier, from the published financial statements.
Net profit-3.11 millionEGP · −5302.5% vs the same period a year earlier
Operating cash flow1.36 millionEGP · −56.8% vs the same period a year earlier
In short
- Future Care for Medical Industries (FCMI)'s net profit for Q2 2025 was about -3.11 million EGP, down −5302.5% from 59.84 thousand EGP in Q2 2024.
- Operating cash flow for Q2 2025 was positive at 1.36 million EGP.
Key lines against the same period a year earlier
This periodQ2 2024Change
Net profit-3.11 million59.84 thousand−5302.5%
Gross profit594 thousand3.42 million−82.6%
Total assets—124 million—
Total liabilities—61.9 million—
Shareholders' equity—62.58 million—
Total liabilities and equity—124 million—
Operating cash flow1.36 million3.14 million−56.8%
Investing cash flow-175 thousand-526 thousand+66.8%
Financing cash flow-576 thousand-915 thousand+37.0%
Net change in cash—1.7 million—
Figures in EGP from the published statement summaries (consolidated where the company publishes consolidated statements), after normalising reporting units across periods. The exact figure is in the attached report, which may be the standalone version. Figures are as shown in the published statement summary; quarterly figures may be cumulative from the start of the fiscal year.
Future Care for Medical Industries (FCMI)'s Q3 2026 results, the day they are published
One email on the day, no account, and a one-click stop in the email itself.
By subscribing you agree to receive these alerts only. Privacy policy